Eastman Chemical Director Defers Fees Into 408 Phantom Stock Units

Eastman Chemical director James J. O'Brien deferred part of his annual retainer into 408 Phantom Stock Units, raising his total holding to 18,137 units. The transaction is considered a neutral compensation event rather than a direct stock purchase or sale.